Laurence M. Corash, Chief Scientific Officer at CERUS CORP (CERS), sold 28,427 shares at $1.97 ($57K) on 2024-03-14, disclosed to the SEC on 2024-03-14.
Scheduled sale ($57k) by Chief Scientific Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.06 | 14,067 | $29K | 50.6% |
| 2 | $1.97 | 14,360 | $28K | 49.4% |
| Total | $2.01 avg | 28,427 | $57K | 100% |
| Filing → |
| CERS | SELL | 2021-03-16 | $303K | — | Filing → |
| CERS | SELL | 2020-03-24 | $63K | — | Filing → |
| CERS | BUY | 2018-03-15 | $866K | — | Filing → |